Description of a pilot anal pap smear screening program among individuals attending a veteran's affairs HIV clinic

AIDS Patient Care and STDs

Volumn 25, Issue 4, 2011, Pages 213-219

  Rosa Cunha, Isabella ^a   Degennaro, Vincent A ^b   Hartmann, Rene ^b   Milikowski, Clara ^a,b   Irizarry, Andres ^b   Heitman, Brenda ^b   Gómez Marín, Orlando ^a,b   Dickinson, Gordon M ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAL INTRAEPITHELIAL NEOPLASIA; ANUS CANCER; ANUS INTERCOURSE; ARTICLE; BIOPSY; CARCINOMA IN SITU; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC IMAGING; FEASIBILITY STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PAPANICOLAOU TEST; SCREENING;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; ANAL CANAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS NEOPLASMS; BIOPSY; CARCINOMA IN SITU; FLORIDA; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 79953816103     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2010.0233     Document Type: Article

References (51)

1. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008;148:728-736.
2. Chiao EY, Krown SE, Stier EA, et al. A population-based analysis of temporal trends in the incidence of squamous anal cancer in relation to the HIV epidemic. J Acquir Immun Defic Syndr 2005;40:451-455. (Pubitemid 41669180)
3. Bower M, Powles T, Newson-Davis T, et al. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr 2004;37:1563-1565.
4. Palefsky JM, Holly EA, Ralston ML, et al. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998;12:495-503. (Pubitemid 28116159)
5. Berry M, Jay N, Cranston R, et al. Progression of high-grade anal intraepithelial neoplasia to invasive cancer among HIV-positive men who have sex with men. 2009 [Abstract 867]. Montreal, Canada: 16th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2009.
6. Palefsky JM, Holly EA, Efirdc JT, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005;19:1407-1414. (Pubitemid 41800677)
7. Piketty C, Darragh TM, Heard I, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite use of highly active antiretroviral therapy. Sex Transm Dis 2004;31:96-99. (Pubitemid 38141642)
8. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92:1500-1510.
9. Wilkin TJ, Palmer S, Brudney KF, et al. Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 2004; 190:1685-1691. (Pubitemid 39411020)
10. Holly EA, Ralston ML, Darragh TM, et al. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001;93:843-849. (Pubitemid 32586612)
11. Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal HPV infection and anal cancer precursors among HIV-infected individuals in the absence of anal intercourse. Ann Intern Med 2003;183:453-459.
12. Grulich AE, Li Y, Macdonald A, et al. rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002;16:1155-1161. (Pubitemid 34533854)
13. Johnson LG, Madeleine MM, Newcomer LM, et al. Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience 1973-2000. Cancer 2004; 101:281-288.
14. Wexler A, Berson AM, Goldstone SE, et al. Invasive anal squamous cell carcinoma in the HIV-positive patient: Outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum 2008;51:73-81.
15. Palefsky JM, Holly EA, Gonzales J, et al. Detection of human papillomavirus in anal intraepithelial neoplasia and anal cancer. Cancer Res 1991;51:1014-1019.
16. Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009;124:2375-2383.
17. Qualters JR, Lee NC, Smith RA, et al. Breast and cervical cancer surveillance, United States, 1973-1987. MMWR CDC Surveill Summ 1992;41:1-7.
18. Hu D, Goldie S. The economic burden of noncervical human papillomavirus diseases in the United States. Am J Obstet Gynecol 2008;198:500.
19. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med 2000;108:634-641. (Pubitemid 30336603)
20. Chiao EY, Giordano TP, Palefsky JM, et al. Screening HIV-infected individuals for anal cancer precursor lesions: A systematic review. Clin Infect Dis 2006;43:223-233.
21. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998;351:1833-1839. (Pubitemid 28279706)
22. Palefsky JM, Holly EA, Hogeboom CJ, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraephitelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Synd Hum Retrovirol 1998;7:314-319.
23. Palefsky JM, Holly E, Ralston MR, et al. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998;177:361-367. (Pubitemid 28063760)
24. Drobacheff C, Dupont P, Mougin C, et al. Anal human papillomavirus DNA screening by Hybrid Capture II in human immunodeficiency virus-positive patients with or without anal intercourse. Eur J Dermatol 2003;13:367-371. (Pubitemid 36963096)
25. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus diseases in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002;35:1127-1134. (Pubitemid 35239474)
26. Scott H, Khoury J, Moore BA, Weissman S, et al. Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinic. Sex Transm Dis 2008;35:197-202. (Pubitemid 351158701)
27. Palefsky JM, Holly EA, Ralston ML, et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr 2001 ;28:422-428. (Pubitemid 34033192)
28. Kiviat NB, Redman M, Hawes S, et al. The effect of HAART on the detection of anal HPV and squamous intraepithelial lesions among HIV infected homosexual men. Bethesda, MD: 6th International Conference on Malignancies in AIDS and Other Immunodeficiencies, 2002.
29. Arain S, Walts AE, Thomas P, Bose S. The anal Pap smear: Cytomorphology of squamous intraepithelial lesions. Cyto-journal 2005;2:4.
30. Mathews WC, Sitapati A, Caperna JC, et al. Measurement characteristics of anal cytology, histopathology, and high resolution anoscopic visual impression in an anal dysplasia screening program. J Acquir Immune Defic Syndr 2004;37:1610-1615. (Pubitemid 39658202)
31. Lytwyn A , Salit IE, Raboud J, et al. Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer 2005;103:1447-1456. (Pubitemid 40410742)
32. Cranston RD, Hart SD, Gornbein JA, et al. The prevalence, and predictive value, of abnormal anal cytology to diagnose anal dysplasia in a population of HIV-positive men who have sex with men. Int J STD AIDS 2007;18:77-80.
33. Arain S, Walts AE, Thomas P, Bose S. The anal pap smear: Cytomorphology of squamous intraepithelial lesions. Cyto-journal 2005;2:4.
34. Vajdic CM, Anderson JS, Hillman RJ, Medley G, Grulich AE. Blind sampling is superior to anoscope guided sampling for screening for anal intraepithelial neoplasia. Sex Transm Infect 2005;81;415-418. (Pubitemid 41494357)
35. Panther LA, Wagner K, Proper J, et al. High resolution anoscopy for men who have sex with men: Inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and the impact of HIV serostatus. Clin Infect Dis 2004;38:1490-1492. (Pubitemid 38668597)
36. Kulasingam SL, KimJJ, Lawrence WF, et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). J Natl Cancer Inst 2006;98:92-100. (Pubitemid 43159963)
37. Goldstone SE, Enyinna CS, Davis TW. Detection of oncogenic human papillomavirus and other predictors of anal high-grade dysplasia in men who have sex with men with abnormal cytology. Dis Colon Rectum 2009;52:31-39.
38. Ho KS, Cranston RD. Anal cytology screening in HIV-positive men who have sex with men: What's new and what's now? Curr Opin Infect Dis 2010;23:21-25.
39. Chang GJ, Berry JM, Jay N, Palefsky JM, Welton ML. Surgical treatment of high-grade anal squamous intraepithelial lesions: A prospective study. Dis Colon Rectum 2002;45:453-458. (Pubitemid 34407722)
40. Nadal SR, Manzione CR, Galvao VM, et al. healing after anal fistulotomy: A comparative study between HIV+ and HIV- patients. Dis Colon Rectum 1998;41:177-179. (Pubitemid 28113243)
41. Abbasakoor F, Boulos PB. Anal intraepithelial neoplasia. Br J Surg 2005;92:277-290. (Pubitemid 40445589)
42. Goldstone SE, Kawalek AZ, Huyett JW. Infrared coagulator: A useful tool for the treatment of anal squamous intraepithelial lesions. Dis Colon Rectum 2005;48:1042-1054. (Pubitemid 40894628)
43. Kreuter A, Hochdorfer B, Stucker M, et al. Treatment of anal intraepithelial neoplasia in patients with acquired HIV with imiquimod 5% cream. J Am Dermatol 2004;50:980-981. (Pubitemid 38685791)
44. Klencke B, Matijevic M, Urban RG, et al. Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a phase I study of ZYC101. Clin Cancer Res 2002; 8:1028-1037. (Pubitemid 34517636)
45. Palefsky JM, Berry JM, Jay N, et al. A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals. AIDS 2006;20:1151-1155. (Pubitemid 43786103)
46. Logan JL, Khambaty MQ, D'Souza KM, Menezes LJ. Cervical cancer screening among HIV-infected women in a health department setting. AIDS Patient Care STDs 2010; 24:471-475.
47. Beckmann CA, Beckmann CRB, Lipscomb GH, King RE, Steere E. Pap smear screening: Determinants of patient compliance. J Womens Health (Larchmt) 1995;4:663-668. (Pubitemid 26038675)
48. Tello MA, Jenckes M, Gaver J, Anderson JR, Moore RD, Chander D. Barriers to Recommended Gynecologic Care in an Urban United States HIV Clinic. J Womens Health (Larchmt) 2010;19:1511-1518.
49. Tiro JA, Meissner HI, Kobrin S, Chollette V. What do women in U.S. know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev 2007; 16:288-294.
50. Pitts MK, Fox C, Willis J, Anderson J. What do gay men know about human papillomavirus? Australian gay men's knowledge and experience of anal cancer screening and human papillomavirus. Sex Transm Dis 2007;34:170-173. (Pubitemid 46673221)
51. Simatherai D, Bradshaw CS, Fairley CK, Bush M, Heley S, Chen MY. What men who have sex with men think about the human papillomavirus vaccine. Sex Transm Infect 2009;85:148-149.